Food supplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle
Therefore, resuscitation equipment (oxygen, IV fluids, cardiac monitor, seizure abortive) must be immediately available whenever large doses or deep blocks are administered
David Smith, urologist and co-founder of medical device company BladGo Medical, told Drugwatch
Educational Opportunities Professionals can leverage cagrilintide knowledge by: Client education Helping clients understand peptide therapy basics, realistic expectations, and the importance of medical supervision Professional development Staying current with metabolic health innovations positions practitioners as knowledgeable resources Collaborative care Understanding dosing protocols facilitates better communication with prescribing providers Outcome monitoring Supporting clients in tracking metrics and recognizing response patterns Supporting Clients on Peptide Protocols When working with individuals using cagrilintide or similar peptides: Lifestyle optimization remains crucial
Patients seeking moderate weight loss (10-15% body weight): Orforglipron's Phase 3 data show mean weight loss of approximately 11% at 72 weeks, with about 55% of participants achieving 10% or greater loss